266 related articles for article (PubMed ID: 21510725)
1. Inhaled iloprost for therapy in pulmonary arterial hypertension.
Ewert R; Gläser S; Bollmann T; Schäper C
Expert Rev Respir Med; 2011 Apr; 5(2):145-52. PubMed ID: 21510725
[TBL] [Abstract][Full Text] [Related]
2. Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension.
Bourge RC; Tapson VF; Safdar Z; Benza RL; Channick RN; Rosenzweig EB; Shapiro S; White RJ; McSwain CS; Gotzkowsky SK; Nelsen AC; Rubin LJ
Cardiovasc Ther; 2013 Feb; 31(1):38-44. PubMed ID: 22970909
[TBL] [Abstract][Full Text] [Related]
3. Inhaled iloprost in pulmonary arterial hypertension.
Baker SE; Hockman RH
Ann Pharmacother; 2005; 39(7-8):1265-74. PubMed ID: 15976392
[TBL] [Abstract][Full Text] [Related]
4. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
[No Abstract] [Full Text] [Related]
5. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
6. Inhalative iloprost - pharmacology and clinical application.
Ewert R; Schäper C; Halank M; Gläser S; Opitz CF
Expert Opin Pharmacother; 2009 Sep; 10(13):2195-207. PubMed ID: 19663611
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
Hoeper MM; Schwarze M; Ehlerding S; Adler-Schuermeyer A; Spiekerkoetter E; Niedermeyer J; Hamm M; Fabel H
N Engl J Med; 2000 Jun; 342(25):1866-70. PubMed ID: 10861321
[TBL] [Abstract][Full Text] [Related]
8. Inhaled iloprost for severe pulmonary hypertension.
Olschewski H; Simonneau G; Galiè N; Higenbottam T; Naeije R; Rubin LJ; Nikkho S; Speich R; Hoeper MM; Behr J; Winkler J; Sitbon O; Popov W; Ghofrani HA; Manes A; Kiely DG; Ewert R; Meyer A; Corris PA; Delcroix M; Gomez-Sanchez M; Siedentop H; Seeger W;
N Engl J Med; 2002 Aug; 347(5):322-9. PubMed ID: 12151469
[TBL] [Abstract][Full Text] [Related]
9. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
Kramm T; Eberle B; Guth S; Mayer E
Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
[TBL] [Abstract][Full Text] [Related]
10. Long-term therapy with inhaled iloprost in patients with pulmonary hypertension.
Olschewski H; Hoeper MM; Behr J; Ewert R; Meyer A; Borst MM; Winkler J; Pfeifer M; Wilkens H; Ghofrani HA; Nikkho S; Seeger W
Respir Med; 2010 May; 104(5):731-40. PubMed ID: 20153158
[TBL] [Abstract][Full Text] [Related]
11. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
12. Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension.
Reichenberger F; Mainwood A; Doughty N; Fineberg A; Morrell NW; Pepke-Zaba J
Respir Med; 2007 Feb; 101(2):217-22. PubMed ID: 16831539
[TBL] [Abstract][Full Text] [Related]
13. lloprost delivered via the BREELIB
Gessler T
Ther Adv Respir Dis; 2019; 13():1753466619835497. PubMed ID: 30874487
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension.
John J; Palevsky H
Expert Rev Clin Pharmacol; 2011 Mar; 4(2):197-205. PubMed ID: 22115402
[TBL] [Abstract][Full Text] [Related]
15. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
Andreassen AK; Madsen S; Kjekshus J; Simonsen S
Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1220-3. PubMed ID: 11402748
[TBL] [Abstract][Full Text] [Related]
16. Review of inhaled iloprost for the control of pulmonary artery hypertension in children.
Tissot C; Beghetti M
Vasc Health Risk Manag; 2009; 5(1):325-31. PubMed ID: 19436672
[TBL] [Abstract][Full Text] [Related]
17. Successful therapy of bosentan-refractory pulmonary arterial hypertension (PAH) with inhalative iloprost.
Ahmadi-Simab K; Lamprecht P; Gross WL
Clin Exp Rheumatol; 2005; 23(3):402-3. PubMed ID: 15971433
[TBL] [Abstract][Full Text] [Related]
18. Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension.
Hoeper MM; Leuchte H; Halank M; Wilkens H; Meyer FJ; Seyfarth HJ; Wensel R; Ripken F; Bremer H; Kluge S; Hoeffken G; Behr J
Eur Respir J; 2006 Oct; 28(4):691-4. PubMed ID: 17012628
[TBL] [Abstract][Full Text] [Related]
19. Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
Schermuly RT; Krupnik E; Tenor H; Schudt C; Weissmann N; Rose F; Grimminger F; Seeger W; Walmrath D; Ghofrani HA
Am J Respir Crit Care Med; 2001 Nov; 164(9):1694-700. PubMed ID: 11719312
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
Wang L; Jin YZ; Zhao QH; Jiang R; Wu WH; Gong SG; He J; Liu JM; Jing ZC
Int J Chron Obstruct Pulmon Dis; 2017; 12():3353-3360. PubMed ID: 29200842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
